A plausible anti-apoptotic role of up-regulated OCT4B1 in bladder tumors.
Author(s) -
Jamshid Asadzadeh,
Malek Hossein Asadi,
Nasser Shakhssalim,
Mahmoud-Reza Rafiee,
Hamid Reza Kalhor,
Mahmoud Tavallaei,
Seyed Javad Mowla
Publication year - 2012
Publication title -
urology journal
Language(s) - English
DOI - 10.22037/uj.v9i3.1595
PURPOSETo investigate and compare the expression of OCT4B1 between tumor and non-tumor bladder tissues.MATERIALS AND METHODSWe investigated the expression of OCT4B1 in 30 tumor and non-tumor surgical specimens of the bladder, using the TaqMan real-time polymerase chain reaction approach and by carefully designing primers and probes specific for the amplification of the variant.RESULTSMost tumor and non-tumor samples of the bladder showed OCT4B1 expression, but its expression level was significantly higher in the tumors (P < .002). Moreover, the up-regulation of OCT4B1 was more significant in high-grade tumors compared to the low-grade ones (P < .05). We have also employed the RNA interference strategy to evaluate the functional role of OCT4B1 in a bladder cancer cell line, 5637. Suppression of OCT4B1 caused some changes in cell cycle distribution, and significantly elevated the rate of apoptosis in the cells.CONCLUSIONOur findings suggest that OCT4B1 plays a potential role in tumor initiation and/or progression of the bladder cancer. Additionally, OCT4B1 can be regarded as a new tumor marker for detection, classification, and treatment of the bladder cancer. However, more experimental studies are needed to replicate our findings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom